背景与目的:碱基切除修复基因对于维护基因组稳定性具有重要的作用,其表达异常与多种肿瘤相关。本实验研究7个重要的碱基切除修复基因(hOGG1,ADPRT,APE1,MBD4,POLB,XRCC1和LIG3)在鼻咽癌及鼻咽非癌组织中的表达及其意义。方法:用RT-PCR方法分析24例鼻咽癌组织和24例鼻咽非癌组织中hOGG1,ADPRT,APE1,MBD4,POLB,XRCC1和LIG3基因的表达。对有表达差异的基因hOGG1和ADPRT进一步用免疫组化的方法在99例鼻咽癌组织和28例鼻咽非癌组织中进行验证。结果:RT-PCR结果表明hOGG1,ADPRT,APE1,MBD4,POLB.XRCC1和LIG3基因在鼻咽癌和鼻咽非癌组织中均表达。其中,hOGG1和ADPRT在鼻咽癌组织中的mRNA水平显著低于鼻咽非癌组织(P〈0.001)。免疫组化验证了两基因的蛋白水平在鼻咽癌组织中降低。在鼻咽癌组织和鼻咽非癌组织中,hOGG1基因高表达率分别50.5%和92.8%(P〈0.001),而ADPRT基因分别是53.5%和96.4%(P〈0.001)。但两基因的表达水平与鼻咽癌的临床分期和预后无关。结论:hOGG1和ADPRT基因的表达降低,可能与鼻咽癌的发生发展密切相关。
BACKGROUND & OBJECTIVE: Base excision repair (BER) genes play important roles in maintaining genomic stability and their abnormal expression are associated with several cancers. This study was to investigate the expression of 7 important BER genes (hOGG1, ADPRT, APE1, MBD4, POLB, XRCC1 and LIG3) in nasopharyngeal carcinoma (NPC) and non-tumor nasopharyngeal tissues, and evaluate their clinical significance. METHODS: The expression of hOGG1, ADPRT, APE1, MBD4, POLB, XRCC1 and LIG3 in 24 specimens of NPC and 24 specimens of non-tumor nasopharyngeal tissues was detected by reverse transcription-polymerase chain reaction (RT-PCR). The differential expression of hOGG1 and ADPRT was further detected by immunohistochemistry in 99 specimens of NPC and 28 specimens of non-tumor nasopharyngeal tissues. RESULTS: hOGG1, ADPRT, APE1, MBD4, POLB, XRCC1 and LIG3 were expressed in both NPC and non-tumor nasopharyngeal tissues. Among them, the mRNA levels of hOGG1 and ADPRT were significantly lower in NPC than in non-tumor nasopharyngeal tissues (P〈0.001). The protein levels of hOGG1 and ADPRT in NPC were also reduced. The high expression rates of hOGG1 were 50.5% in NPC and and 92.8% in non-tumor nasopharyngeal tissues (P〈0.001), and those of ADPRT were 53.5% and 96.4%, respectively (P〈0.001). However, the expression levels of hOGG1 and ADPRT had no correlations to the clinical stage and prognosis of NPC. CONCLUSION: The decreased expression of hOGG1 and ADPRT might be closely related to the development of nasopharyngeal carcinoma.